CIA
CVS icon

Capital Investment Advisors’s CVS Health CVS Stock Holding History

Capital Investment Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.45M Sell
61,904
-4,031
-6% -$311K 0.07% 158
2025
Q4 		$5.23M Sell
65,935
-2,959
-4% -$233K 0.08% 152
2025
Q3 		$5.19M Sell
68,894
-9,190
-12% -$630K 0.09% 143
2025
Q2 		$5.39M Sell
78,084
-10,382
-12% -$681K 0.1% 141
2025
Q1 		$5.99M Sell
88,466
-321,142
-78% -$19.2M 0.12% 130
2024
Q4 		$18.4M Sell
409,608
-94,891
-19% -$5.32M 0.37% 66
2024
Q3 		$31.7M Buy
504,499
+73,269
+17% +$4.27M 0.65% 46
2024
Q2 		$25.5M Buy
431,230
+2,058
+0.5% +$129K 0.58% 54
2024
Q1 		$34.2M Sell
429,172
-4,790
-1% -$366K 0.8% 33
2023
Q4 		$34.3M Sell
433,962
-2,645
-0.6% -$188K 0.86% 31
2023
Q3 		$30.5M Buy
436,607
+43,700
+11% +$3.1M 0.84% 31
2023
Q2 		$27.2M Buy
392,907
+42,787
+12% +$3.04M 0.83% 30
2023
Q1 		$26M Buy
350,120
+205,035
+141% +$17.2M 0.77% 38
2022
Q4 		$13.5M Buy
145,085
+2,141
+1% +$207K 0.41% 63
2022
Q3 		$13.6M Buy
142,944
+493
+0.3% +$48.8K 0.47% 58
2022
Q2 		$13.2M Sell
142,451
-3,062
-2% -$299K 0.44% 62
2022
Q1 		$14.7M Buy
145,513
+2,286
+2% +$240K 0.45% 54
2021
Q4 		$14.8M Buy
143,227
+6,134
+4% +$567K 0.45% 53
2021
Q3 		$11.6M Buy
137,093
+3,627
+3% +$304K 0.39% 61
2021
Q2 		$11.1M Buy
133,466
+2,628
+2% +$215K 0.38% 59
2021
Q1 		$9.84M Buy
130,838
+7,860
+6% +$573K 0.37% 62
2020
Q4 		$8.4M Buy
122,978
+16,793
+16% +$1.09M 0.35% 64
2020
Q3 		$6.2M Buy
106,185
+3,808
+4% +$237K 0.3% 71
2020
Q2 		$6.65M Buy
102,377
+2,406
+2% +$152K 0.34% 65
2020
Q1 		$5.93M Buy
99,971
+6,911
+7% +$461K 0.38% 60
2019
Q4 		$6.91M Buy
93,060
+25,058
+37% +$1.76M 0.33% 77
2019
Q3 		$4.29M Buy
68,002
+24,258
+55% +$1.44M 0.22% 104
2019
Q2 		$2.38M Buy
43,744
+19,451
+80% +$1.05M 0.13% 135
2019
Q1 		$1.31M Buy
24,293
+2,295
+10% +$142K 0.08% 189
2018
Q4 		$1.44M Buy
21,998
+1,848
+9% +$138K 0.1% 166
2018
Q3 		$1.59M Buy
20,150
+224
+1% +$16K 0.09% 166
2018
Q2 		$1.28M Buy
19,926
+1,939
+11% +$128K 0.08% 182
2018
Q1 		$1.12M Buy
17,987
+1,949
+12% +$140K 0.07% 199
2017
Q4 		$1.16M Buy
16,038
+2,244
+16% +$163K 0.08% 195
2017
Q3 		$1.12M Buy
13,794
+315
+2% +$24.9K 0.08% 193
2017
Q2 		$1.08M Buy
13,479
+1,023
+8% +$80.8K 0.08% 192
2017
Q1 		$978K Buy
12,456
+1,268
+11% +$101K 0.07% 207
2016
Q4 		$883K Buy
11,188
+393
+4% +$31.8K 0.07% 210
2016
Q3 		$961K Buy
10,795
+26
+0.2% +$2.45K 0.08% 199
2016
Q2 		$1.03M Sell
10,769
-964
-8% -$96.1K 0.1% 185
2016
Q1 		$1.22M Sell
11,733
-102
-0.9% -$9.92K 0.12% 153
2015
Q4 		$1.16M Buy
11,835
+3,391
+40% +$332K 0.12% 154
2015
Q3 		$815K Buy
8,444
+471
+6% +$49.5K 0.09% 181
2015
Q2 		$836K Buy
7,973
+5,224
+190% +$534K 0.09% 187
2015
Q1 		$284K Buy
+2,749
New +$278K 0.03% 322

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital Investment Advisors's CVS Position: Q1 2026 in Review

Capital Investment Advisors reduced its CVS Health (CVS) stake by 6.1% in Q1 2026, selling an estimated $311K and leaving 61,904 shares worth $4.45M. The position accounts for 0.07% of the portfolio, ranked #158.

Capital Investment Advisors first reported a position in CVS in Q1 2015 and has held it in 45 quarters since. The position peaked at $34.3M in Q4 2023. 1,866 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Capital Investment Advisors held 61,904 shares of CVS Health worth $4.45M as of Q1 2026.
  • Capital Investment Advisors sold 4,031 CVS Health shares in Q1 2026, an estimated $311K.
  • CVS Health made up 0.07% of Capital Investment Advisors's portfolio in Q1 2026, its #158 holding.
  • Capital Investment Advisors first reported a position in CVS Health in Q1 2015 and has held it in 45 quarters since.
  • Capital Investment Advisors's CVS Health position peaked at $34.3M in Q4 2023.
  • 1,866 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Capital Investment Advisors's 13F filing for Q1 2026, filed 16 Apr 2026.